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Objective
The goal is this study is to design and deliver 
bilirubin nanoparticles and quercetin 
nanoparticles to beta cells in order to improve 
post-hypoxia survival outcomes for islet 
transplantation.
Introduction
The most direct curative therapy for type I 
diabetes involves transplanting islets from a 
healthy donor to restore normoglycemia in the 
afflicted patient. However, even with 
advancements in transplantation, 60% to 80% of 
the isolated islets frequently die upon exposure to 
a hypoxic environment outside the body. 
Recent studies have demonstrated that two 
candidate antioxidants, bilirubin and quercetin, 
can significantly increase beta cell viability under 
hypoxic stress. Therefore, PLGA-PF-127 polymeric 
nanoparticles surface-coated with chitosan were 
encapsulated with bilirubin and quercetin for 
delivery to beta cells to increase drug uptake and 
cell viability post-hypoxia.
Figure 2. TEM images of bilirubin (A) and quercetin (B) 
nanoparticles
Nanoparticle Characterization
The single emulsion nanoparticles demonstrated 
~25% encapsulation efficiency and ~200 nm in size 
with a polydispersity index less than 0.1 for all 














Bilirubin 26.7±0.24 1.27±0.01 190.5±54.74 8.94±6.89 
Quercetin 24.9±0.65 4.98±0.13 202.0±64.79 6.98±6.85 
Control 
Nanoparticles 
N/A N/A 187.7±45.38 4.22±5.22 
 
Table 1. Characteristics of bilirubin and quercetin 
nanoparticles
Figure 1. Antioxidant effects of bilirubin
Cellular Uptake
For both MCF-7 and TC-6 cells, nanoparticle-
encapsulated bilirubin exhibited increased uptake 
compared to free bilirubin in a dose-dependent 
manner. 
Figure 3. Uptake of nanoparticle (NP)-encapsulated 
and free bilirubin (10 μM)
Conclusions
Nanoparticle Effect on Cell Viability Post-Hypoxia
The group treated with 40 μM of 
nanoparticle-encapsulated bilirubin 
and nanoparticle-encapsulated 
quercetin witnessed significantly 
higher cell viability than the control 
group with no drug treatment (p = 
0.017) as well as free bilirubin (p = 
0.0039), free quercetin (p = 0.0007), 
nanoparticle quercetin (p = 0.017), 
and free bilirubin and quercetin (p = 
0.0008) of the same concentration. 
Figure 4. Mean viability of TC-6 cells treated with different 
concentrations of nano-encapsulated or free bilirubin and quercetin
and exposed to 24 hr hypoxia 
The results of the study demonstrate sufficient 
encapsulation efficiency, positive zeta potential, 
and polydispersity index of the nanoparticles, 
which were taken up much more readily into TC-6 
cells than their free drug counterparts. 
Pretreatment of the TC-6 cells with nanoparticle-
encapsulated bilirubin and quercetin, at 40 μM, 
before exposure to 24 hours of hypoxia resulted in 
significant increase in cell number and potentially 
increased viability compared to controls with no 
drug treatment. Future studies will corroborate 
the cytoprotective effects of this nanoparticle-
mediated combination on murine pancreatic islets 
and confirm the preservation of glucose-
stimulated insulin secretion. The discovery of this 
combinatory therapy of antioxidant nanoparticles 
could preserve islet mass more efficiently, 
reducing donors needed and improving 
therapeutic outcomes for patients with type 1 
diabetes.
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